Research conference summary from the 2014 International Task Force on ATP1A3-related disorders

Hendrik Rosewich, Matthew T. Sweney, Suzanne Debrosse, Kevin Ess, Laurie Ozelius, Eva Andermann, Frederick Andermann, Gene Andrasco, Alice Belgrade, Allison Brashear, Sharon Ciccodicola, Lynn Egan, Alfred L. George, Aga Lewelt, Joshua Magelby, Mario Merida, Tara Newcomb, Vicky Platt, Dominic Poncelin, Sandra ReynaMasayuki Sasaki, Marcio Sotero De Menezes, Kathleen Sweadner, Louis Viollet, Mary Zupanc, Kenneth Silver, Kathryn Swoboda

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: ATP1A3-related neurologic disorders encompass a broad range of phenotypes that extend well beyond initial phenotypic criteria associated with alternating hemiplegia of childhood (AHC) and rapid-onset dystonia parkinsonism. Methods: In 2014, the Alternating Hemiplegia of Childhood Foundation hosted a multidisciplinary workshop intended to address fundamental challenges surrounding the diagnosis and management of individuals with ATP1A3-related disorders. Results: Workshop attendees were charged with the following: (1) to achieve consensus on expanded diagnostic criteria to facilitate the identification of additional patients, intended to supplement existing syndrome-specific diagnostic paradigms; (2) to standardize definitions for the broad range of paroxysmal manifestations associated with AHC to disseminate to families; (3) to create clinical recommendations for common recurrent issues facing families and medical care providers; (4) to review data related to the death of individuals in the Alternating Hemiplegia of Childhood Foundation database to guide future efforts in identifying at-risk subjects and potential preventative measures; and (5) to identify critical gaps where we most need to focus national and international research efforts. Conclusions: This report summarizes recommendations of the workshop committee, highlighting the key phenotypic features to facilitate the diagnosis of possible ATP1A3 mutations, providing recommendations for genetic testing, and outlining initial acute management for common recurrent clinical conditions, including epilepsy.

Original languageEnglish (US)
Article numbere139
JournalNeurology: Genetics
Volume3
Issue number2
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Advisory Committees
Education
Research
Dystonic Disorders
Genetic Testing
Nervous System Diseases
Epilepsy
Consensus
Databases
Phenotype
Mutation
Alternating hemiplegia of childhood

ASJC Scopus subject areas

  • Clinical Neurology
  • Genetics(clinical)

Cite this

Rosewich, H., Sweney, M. T., Debrosse, S., Ess, K., Ozelius, L., Andermann, E., ... Swoboda, K. (2017). Research conference summary from the 2014 International Task Force on ATP1A3-related disorders. Neurology: Genetics, 3(2), [e139]. https://doi.org/10.1212/NXG.0000000000000139

Research conference summary from the 2014 International Task Force on ATP1A3-related disorders. / Rosewich, Hendrik; Sweney, Matthew T.; Debrosse, Suzanne; Ess, Kevin; Ozelius, Laurie; Andermann, Eva; Andermann, Frederick; Andrasco, Gene; Belgrade, Alice; Brashear, Allison; Ciccodicola, Sharon; Egan, Lynn; George, Alfred L.; Lewelt, Aga; Magelby, Joshua; Merida, Mario; Newcomb, Tara; Platt, Vicky; Poncelin, Dominic; Reyna, Sandra; Sasaki, Masayuki; De Menezes, Marcio Sotero; Sweadner, Kathleen; Viollet, Louis; Zupanc, Mary; Silver, Kenneth; Swoboda, Kathryn.

In: Neurology: Genetics, Vol. 3, No. 2, e139, 01.01.2017.

Research output: Contribution to journalArticle

Rosewich, H, Sweney, MT, Debrosse, S, Ess, K, Ozelius, L, Andermann, E, Andermann, F, Andrasco, G, Belgrade, A, Brashear, A, Ciccodicola, S, Egan, L, George, AL, Lewelt, A, Magelby, J, Merida, M, Newcomb, T, Platt, V, Poncelin, D, Reyna, S, Sasaki, M, De Menezes, MS, Sweadner, K, Viollet, L, Zupanc, M, Silver, K & Swoboda, K 2017, 'Research conference summary from the 2014 International Task Force on ATP1A3-related disorders', Neurology: Genetics, vol. 3, no. 2, e139. https://doi.org/10.1212/NXG.0000000000000139
Rosewich, Hendrik ; Sweney, Matthew T. ; Debrosse, Suzanne ; Ess, Kevin ; Ozelius, Laurie ; Andermann, Eva ; Andermann, Frederick ; Andrasco, Gene ; Belgrade, Alice ; Brashear, Allison ; Ciccodicola, Sharon ; Egan, Lynn ; George, Alfred L. ; Lewelt, Aga ; Magelby, Joshua ; Merida, Mario ; Newcomb, Tara ; Platt, Vicky ; Poncelin, Dominic ; Reyna, Sandra ; Sasaki, Masayuki ; De Menezes, Marcio Sotero ; Sweadner, Kathleen ; Viollet, Louis ; Zupanc, Mary ; Silver, Kenneth ; Swoboda, Kathryn. / Research conference summary from the 2014 International Task Force on ATP1A3-related disorders. In: Neurology: Genetics. 2017 ; Vol. 3, No. 2.
@article{11696c9db0e34701805f477ec833bd8e,
title = "Research conference summary from the 2014 International Task Force on ATP1A3-related disorders",
abstract = "Objective: ATP1A3-related neurologic disorders encompass a broad range of phenotypes that extend well beyond initial phenotypic criteria associated with alternating hemiplegia of childhood (AHC) and rapid-onset dystonia parkinsonism. Methods: In 2014, the Alternating Hemiplegia of Childhood Foundation hosted a multidisciplinary workshop intended to address fundamental challenges surrounding the diagnosis and management of individuals with ATP1A3-related disorders. Results: Workshop attendees were charged with the following: (1) to achieve consensus on expanded diagnostic criteria to facilitate the identification of additional patients, intended to supplement existing syndrome-specific diagnostic paradigms; (2) to standardize definitions for the broad range of paroxysmal manifestations associated with AHC to disseminate to families; (3) to create clinical recommendations for common recurrent issues facing families and medical care providers; (4) to review data related to the death of individuals in the Alternating Hemiplegia of Childhood Foundation database to guide future efforts in identifying at-risk subjects and potential preventative measures; and (5) to identify critical gaps where we most need to focus national and international research efforts. Conclusions: This report summarizes recommendations of the workshop committee, highlighting the key phenotypic features to facilitate the diagnosis of possible ATP1A3 mutations, providing recommendations for genetic testing, and outlining initial acute management for common recurrent clinical conditions, including epilepsy.",
author = "Hendrik Rosewich and Sweney, {Matthew T.} and Suzanne Debrosse and Kevin Ess and Laurie Ozelius and Eva Andermann and Frederick Andermann and Gene Andrasco and Alice Belgrade and Allison Brashear and Sharon Ciccodicola and Lynn Egan and George, {Alfred L.} and Aga Lewelt and Joshua Magelby and Mario Merida and Tara Newcomb and Vicky Platt and Dominic Poncelin and Sandra Reyna and Masayuki Sasaki and {De Menezes}, {Marcio Sotero} and Kathleen Sweadner and Louis Viollet and Mary Zupanc and Kenneth Silver and Kathryn Swoboda",
year = "2017",
month = "1",
day = "1",
doi = "10.1212/NXG.0000000000000139",
language = "English (US)",
volume = "3",
journal = "Neurology: Genetics",
issn = "2376-7839",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Research conference summary from the 2014 International Task Force on ATP1A3-related disorders

AU - Rosewich, Hendrik

AU - Sweney, Matthew T.

AU - Debrosse, Suzanne

AU - Ess, Kevin

AU - Ozelius, Laurie

AU - Andermann, Eva

AU - Andermann, Frederick

AU - Andrasco, Gene

AU - Belgrade, Alice

AU - Brashear, Allison

AU - Ciccodicola, Sharon

AU - Egan, Lynn

AU - George, Alfred L.

AU - Lewelt, Aga

AU - Magelby, Joshua

AU - Merida, Mario

AU - Newcomb, Tara

AU - Platt, Vicky

AU - Poncelin, Dominic

AU - Reyna, Sandra

AU - Sasaki, Masayuki

AU - De Menezes, Marcio Sotero

AU - Sweadner, Kathleen

AU - Viollet, Louis

AU - Zupanc, Mary

AU - Silver, Kenneth

AU - Swoboda, Kathryn

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective: ATP1A3-related neurologic disorders encompass a broad range of phenotypes that extend well beyond initial phenotypic criteria associated with alternating hemiplegia of childhood (AHC) and rapid-onset dystonia parkinsonism. Methods: In 2014, the Alternating Hemiplegia of Childhood Foundation hosted a multidisciplinary workshop intended to address fundamental challenges surrounding the diagnosis and management of individuals with ATP1A3-related disorders. Results: Workshop attendees were charged with the following: (1) to achieve consensus on expanded diagnostic criteria to facilitate the identification of additional patients, intended to supplement existing syndrome-specific diagnostic paradigms; (2) to standardize definitions for the broad range of paroxysmal manifestations associated with AHC to disseminate to families; (3) to create clinical recommendations for common recurrent issues facing families and medical care providers; (4) to review data related to the death of individuals in the Alternating Hemiplegia of Childhood Foundation database to guide future efforts in identifying at-risk subjects and potential preventative measures; and (5) to identify critical gaps where we most need to focus national and international research efforts. Conclusions: This report summarizes recommendations of the workshop committee, highlighting the key phenotypic features to facilitate the diagnosis of possible ATP1A3 mutations, providing recommendations for genetic testing, and outlining initial acute management for common recurrent clinical conditions, including epilepsy.

AB - Objective: ATP1A3-related neurologic disorders encompass a broad range of phenotypes that extend well beyond initial phenotypic criteria associated with alternating hemiplegia of childhood (AHC) and rapid-onset dystonia parkinsonism. Methods: In 2014, the Alternating Hemiplegia of Childhood Foundation hosted a multidisciplinary workshop intended to address fundamental challenges surrounding the diagnosis and management of individuals with ATP1A3-related disorders. Results: Workshop attendees were charged with the following: (1) to achieve consensus on expanded diagnostic criteria to facilitate the identification of additional patients, intended to supplement existing syndrome-specific diagnostic paradigms; (2) to standardize definitions for the broad range of paroxysmal manifestations associated with AHC to disseminate to families; (3) to create clinical recommendations for common recurrent issues facing families and medical care providers; (4) to review data related to the death of individuals in the Alternating Hemiplegia of Childhood Foundation database to guide future efforts in identifying at-risk subjects and potential preventative measures; and (5) to identify critical gaps where we most need to focus national and international research efforts. Conclusions: This report summarizes recommendations of the workshop committee, highlighting the key phenotypic features to facilitate the diagnosis of possible ATP1A3 mutations, providing recommendations for genetic testing, and outlining initial acute management for common recurrent clinical conditions, including epilepsy.

UR - http://www.scopus.com/inward/record.url?scp=85032659740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032659740&partnerID=8YFLogxK

U2 - 10.1212/NXG.0000000000000139

DO - 10.1212/NXG.0000000000000139

M3 - Article

AN - SCOPUS:85032659740

VL - 3

JO - Neurology: Genetics

JF - Neurology: Genetics

SN - 2376-7839

IS - 2

M1 - e139

ER -